{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02243",
      "entity_text" : "hs-CRP",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0445" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Rivaroxaban and VKA treatments were associated with reductions from baseline in levels of D-dimer (-32.3 and -37.6%, respectively), TAT (-28.0 and -23.1%, respectively), hs-CRP (-12.5 and -17.9%, respectively), and hs-IL-6 (-9.2 and -9.8%, respectively).",
  "reading_complete" : "2020-08-02T12:47:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:42:14Z",
  "trigger" : "levels",
  "evidence" : [ "levels of D-dimer (-32.3 and -37.6%, respectively), TAT (-28.0 and -23.1%, respectively), hs-CRP" ],
  "pmc_id" : "6978177",
  "score" : 0
}